Jun 2026 (Q2 FY26) — Aug 13, 2026
MDxHealth Q2 FY26 — Strong Sequential Revenue Growth and De-risking
Read the full callMDxHealth earnings: last reported Thu, 13 Aug 2026, for the quarter ended Jun 2026.
Price
1Y: $4.01 on 17 Oct 2025 → $0.18. High $5 (28 Oct 2025), low $0.18 (19 Oct 2026).
Overview
Call summaries
MDxHealth Q2 FY26 — Strong Sequential Revenue Growth and De-risking
Read the full callEvery analysed call
Financials
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total liabilities | — | 26 | 28 | 110 | 122 | 142 | 160 |
| Fixed assets | — | 1 | 2 | 4 | 5 | 4 | 5 |
| Total assets | — | 32 | 75 | 119 | 129 | 157 | 148 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -22 | -20 | -23 | -34 | -21 | -19 | -2 |
| Cash from investing | -0 | -1 | -1 | -29 | -4 | -2 | -19 |
| Cash from financing | 18 | 14 | 66 | 21 | 32 | 45 | 3 |
| Net cash flow | — | — | — | -42 | 7 | 24 | -18 |
| Capital expenditure | -0 | -1 | -1 | -3 | -3 | -1 | -1 |
| Free cash flow | -22 | -21 | -23 | -37 | -24 | -20 | -3 |
1 filing, all on Aug 13, 2026.
Purchases
$1000.0K
1 purchase by 1 insider
Sales
None
No insider sold shares.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| MVM Partners, LLC | $1000.0K | — | Aug 13, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | MVM Partners, LLC Director | Purchase | 2,202,643 | $1000.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow MDxHealth SA and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading